RISPOLI, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 2.768
EU - Europa 243
NA - Nord America 200
SA - Sud America 33
AF - Africa 3
Totale 3.247
Nazione #
HK - Hong Kong 2.611
US - Stati Uniti d'America 197
SG - Singapore 93
IT - Italia 86
RU - Federazione Russa 60
DE - Germania 44
CN - Cina 31
BR - Brasile 28
FI - Finlandia 13
ES - Italia 8
IN - India 7
NL - Olanda 7
IE - Irlanda 6
AT - Austria 5
BD - Bangladesh 4
GB - Regno Unito 4
IR - Iran 4
JP - Giappone 4
KR - Corea 4
VN - Vietnam 4
SE - Svezia 3
CO - Colombia 2
EC - Ecuador 2
IQ - Iraq 2
TR - Turchia 2
UA - Ucraina 2
AR - Argentina 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
FR - Francia 1
IL - Israele 1
KE - Kenya 1
LU - Lussemburgo 1
LY - Libia 1
MX - Messico 1
PA - Panama 1
PL - Polonia 1
TH - Thailandia 1
Totale 3.247
Città #
Hong Kong 2.611
Dallas 58
Singapore 32
Munich 28
Chandler 24
Ashburn 23
Moscow 15
Princeton 11
Naples 10
Turku 10
Beijing 7
Würselen 7
Ann Arbor 6
Boardman 6
Domicella 6
Fisciano 6
Los Angeles 6
Nuremberg 6
Sarno 5
Council Bluffs 4
Dublin 4
Rome 4
Tokyo 4
Afragola 3
Atlanta 3
Castelfranco in Miscano 3
Manocalzati 3
Pune 3
Tehran 3
Vienna 3
Wilmington 3
Ankara 2
Arba 2
Arzano 2
Baghdad 2
Cava de' Tirreni 2
Chennai 2
Helsinki 2
Ho Chi Minh City 2
New York 2
Phoenix 2
Poplar 2
Salerno 2
San Francisco 2
Seattle 2
Seoul 2
Stockholm 2
The Dalles 2
Trento 2
Abidjan 1
Acerra 1
Amsterdam 1
Andover 1
Aracaju 1
Arcoverde 1
Aversa 1
Bangkok 1
Bari 1
Bastrop 1
Belford Roxo 1
Boston 1
Brno 1
Calçado 1
Carapicuíba 1
Carinola 1
Catalão 1
Cleveland 1
Columbus 1
Concord 1
Contagem 1
Criciúma 1
Curvelo 1
Florianópolis 1
Fredericksburg 1
Garça 1
Guayaquil 1
Hanoi 1
Hanover 1
Houston 1
Imbituba 1
Istra 1
Jacksonville 1
Jiaxing 1
Jinan 1
Joinville 1
Lappeenranta 1
Levittown 1
Lomas del Mirador 1
Luxembourg 1
Milan 1
Montano Antilia 1
Mumbai 1
Nairobi 1
Nola 1
Panama City 1
Patna 1
Paulínia 1
Penápolis 1
Perdizes 1
Pitimbu 1
Totale 3.004
Nome #
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 859
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019 654
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 495
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 422
The favourable alliance between cardiomems and levosimendan in patients with advanced heart failure 188
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy) 180
An explainable model for predicting Worsening Heart Failure based on genetic programming 97
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 85
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 75
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 48
Vitamin D: A Bridge between Kidney and Heart. 46
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function 40
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 33
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better 28
Wearable Technologies and AI at the Far Edge for Chronic Heart Failure Prevention and Management: A Systematic Review and Prospects 23
Totale 3.273
Categoria #
all - tutte 6.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 3 6 0 0 3 2 1 3 1
2021/202225 0 0 0 0 0 0 12 2 1 1 1 8
2022/202359 3 7 15 7 3 8 0 8 3 1 2 2
2023/202495 1 2 6 2 11 13 4 5 0 6 3 42
2024/2025308 4 3 2 14 14 21 72 15 63 8 41 51
2025/20262.761 848 1.138 767 8 0 0 0 0 0 0 0 0
Totale 3.273